Today: 9 May 2026
Browse Category

NASDAQ:NXPL 13 April 2026

Upcoming Stock Splits This Week: Nasdaq Reverse Splits Pile Up as Booking, Powell and Pashupati Stand Apart

Upcoming Stock Splits This Week: Nasdaq Reverse Splits Pile Up as Booking, Powell and Pashupati Stand Apart

NextPlat, MultiSensor AI, Cenntro, and Quince Therapeutics will begin trading Monday on a reverse-split basis, with ratios ranging from 1-for-10 to 1-for-60. Several other Nasdaq-listed firms, including Huachen AI Parking and Akanda, are also set for reverse splits. Last week saw forward splits from Booking Holdings and Powell Industries. Cenntro and Quince both disclosed ongoing Nasdaq compliance concerns.
13 April 2026
·······

Stock Market Today

  • Morgan Stanley Lowers Gilead Sciences Price Target Amid Mixed Analyst Ratings
    May 9, 2026, 10:30 AM EDT. Morgan Stanley cut Gilead Sciences' (NASDAQ:GILD) price target from $175 to $168, signaling a pessimistic outlook despite a potential 27.92% upside. Other firms show mixed sentiment: Goldman Sachs raised target to $130 with a neutral rating, while Bank of America and Citigroup issued buy ratings with targets above $160. Gilead's recent quarterly earnings beat expectations, reporting $2.03 EPS versus $1.91 estimated and revenue of $6.96 billion. The stock trades near $131.33 with a market cap of $163 billion and a P/E ratio of 17.89. CEO Daniel O'Day sold 10,000 shares recently, indicating insider activity amid this uncertain environment. Overall consensus rating remains moderate buy with an average target price of $157.15.

Latest article

Hims & Hers Stock (HIMS) Faces a GLP-1 Test as Q1 Earnings Loom

Hims & Hers Stock (HIMS) Faces a GLP-1 Test as Q1 Earnings Loom

9 May 2026
Hims & Hers Health shares rose 10.2% to $28.27 on Friday ahead of first-quarter results due Monday. Analysts expect Q1 revenue near $616.9 million and earnings of 3 cents per share. The company recently reached a deal with Novo Nordisk to offer Ozempic and Wegovy, and added Eli Lilly’s Zepbound and Foundayo to its platform. The FDA is considering tighter rules on compounding GLP-1 drugs.
Trump Media & Technology Group’s $406 Million Loss Puts DJT Stock Back Under the Microscope

Trump Media & Technology Group’s $406 Million Loss Puts DJT Stock Back Under the Microscope

9 May 2026
Trump Media & Technology Group posted a $405.9 million first-quarter net loss on $871,200 in sales, driven by $244 million in unrealized crypto losses and $108.2 million in investment losses. The company ended March with $2.2 billion in assets, including 9,542 bitcoin and 756 million Cronos tokens. Cash from operations totaled $17.9 million. DJT shares closed at $8.93 Friday, valuing the firm at $2.48 billion.
Seagate Stock Rides AI Storage Boom as STX Rally Faces a Valuation Test

Seagate Stock Rides AI Storage Boom as STX Rally Faces a Valuation Test

9 May 2026
Seagate shares closed at $782.64 Friday, near record highs, as investors bet on rising demand for hard drives in AI-driven data storage. The company last reported fiscal Q3 revenue of $3.11 billion and forecast Q4 revenue of $3.45 billion. Morgan Stanley raised its price target to $767, citing strong pricing and earnings. Seagate’s market value stood at $179.2 billion with a P/E ratio near 74.
Go toTop